Cargando…

COVID-19 AND NEUROMUSCULAR DISEASES: EP.24 COVID-19 mitigation strategies for outcome measure assessments, training, and endpoint collection in clinic, clinical trials and natural history studies

Detalles Bibliográficos
Autores principales:	James, M., Alfano, L., Rose, K., Lowes, L., Eagle, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449708/ http://dx.doi.org/10.1016/j.nmd.2021.07.049

Ejemplares similares

Remote Delivery of Motor Function Assessment and Training for Clinical Trials in Neuromuscular Disease: A Response to the COVID-19 Global Pandemic
por: James, Meredith K., et al.
Publicado: (2021)

COVID-19 AND NEUROMUSCULAR DISEASES: EP.22 COVID-19 in children with neuromuscular disorders
por: Natera-de Benito, D., et al.
Publicado: (2021)

COVID-19 AND NEUROMUSCULAR DISEASES: EP.21 COVID-19 pandemia: Physical, psychological and social impact of lockdown on neuromuscular patients.
por: Delstanche, S., et al.
Publicado: (2021)

Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy: A GRASP-LGMD study
por: Doody, Amy, et al.
Publicado: (2023)

The importance of appropriate selection of clinical endpoints in outpatient COVID-19 clinical trials
por: Thorlund, Kristian, et al.
Publicado: (2023)

OUTCOME MEASURES: EP.325 Remote testing: is it worth the effort? Feasibility in the clinical and research setting
por: Powers, B., et al.
Publicado: (2021)

Statistical mitigation of COVID-19 pandemic disruptions to growth data collection in clinical studies
por: Choe, Y., et al.
Publicado: (2020)

Consensus Guidelines for Improving Quality of Assessment and Training for Neuromuscular Diseases
por: Duong, Tina, et al.
Publicado: (2021)

Experience with telemedicine in neuromuscular clinic during COVID-19 pandemic
por: Ghasemi, Mehdi, et al.
Publicado: (2023)

Selecting appropriate endpoints for assessing treatment effects in comparative clinical studies for COVID-19
por: McCaw, Zachary R., et al.
Publicado: (2020)

Evaluating Clinical Efficacy of Antiviral Therapy for COVID-19: A Surrogate Endpoint Approach
por: Jen, Hsiao-Hsuan, et al.
Publicado: (2021)

COVID-19 AND NEUROMUSCULAR DISEASES: EP.19 Facial Onset Acute Inflammatory Demyelinating Polyneuropathy Related to SARS-CoV-2
por: Alaamel, A., et al.
Publicado: (2021)

COVID 19: Neuromuscular Manifestations
por: Benny, Rajesh, et al.
Publicado: (2020)

COVID-19: Neuromuscular Manifestations
por: Benny, Rajesh, et al.
Publicado: (2021)

COVID-19 AND NEUROMUSCULAR DISEASES: EP.20 The change in weight gain during the coronavirus pandemic in children with Duchenne muscular dystrophy
por: Alhaswani, Z.
Publicado: (2021)

Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature
por: Schoser, Benedikt, et al.
Publicado: (2017)

Impact of Tele-Neuromuscular Clinic on the Accessibility of Care for Patients with Inherited Neuromuscular Disorders during COVID-19 Pandemic in India
por: Reyaz, Alisha, et al.
Publicado: (2022)

Mitigating the Impact of COVID-19 on Funded Clinical Research: Crucial Next Steps
por: Walker, Rebekah J., et al.
Publicado: (2020)

COVID-19 in Colombia endpoints. Are we different, like Europe?
por: Amariles, Pedro, et al.
Publicado: (2021)

EPS1.07 Impact of COVID-19 on cystic fibrosis physiotherapy outpatient clinics
por: Scott, E., et al.
Publicado: (2021)

Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery
por: Douin, David J., et al.
Publicado: (2022)

Neuromuscular presentations in patients with COVID-19
por: Paliwal, Vimal Kumar, et al.
Publicado: (2020)

COVID-19 in children with neuromuscular disorders
por: Natera-de Benito, Daniel, et al.
Publicado: (2021)

Neuromuscular Involvement in COVID-19 Patients
por: Finsterer, Josef
Publicado: (2021)

Neurologic and Neuromuscular Sequelae of COVID-19
por: Li, Carol, et al.
Publicado: (2023)

Neuromuscular Disorders Associated With COVID-19
por: Morgan, Larry, et al.
Publicado: (2023)

Integrating oral PrEP delivery among African women in a large HIV endpoint‐driven clinical trial
por: Beesham, Ivana, et al.
Publicado: (2020)

861. Impact of COVID-19 Mitigation Measures on PrEP Care at a Safety Net Health System in Atlanta
por: Cantos, Valeria D, et al.
Publicado: (2021)

EP14 COVID-19 associated aortitis
por: Zou, Yun, et al.
Publicado: (2020)

Do Diet and Dietary Supplements Mitigate Clinical Outcomes in COVID-19?
por: Singh, Bhavdeep, et al.
Publicado: (2022)

Impact of COVID-19 on management of clinical trials and the potential mitigating strategies
por: Sarve, Parag, et al.
Publicado: (2023)

eP217: Ophthalmology genetics clinic in the times of COVID-19: A hybrid model
por: Pritchard, Amanda, et al.
Publicado: (2022)

Updating clinical endpoint definitions
por: Hassoun, Paul M., et al.
Publicado: (2013)

Neuromuscular Diseases Care in the Era of COVID-19
por: Bertran Recasens, Bernat, et al.
Publicado: (2020)

Neuromuscular blockade management in patients with COVID-19
por: Chaves-Cardona, Harold, et al.
Publicado: (2021)

COVID-19: Mitigation or suppression?
por: Kassem, Abdel Meguid
Publicado: (2020)

Factors associated with the severity of COVID‐19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID‐19 Registry
por: Pizzamiglio, Chiara, et al.
Publicado: (2022)

OUTCOME MEASURES: EP.324 TREAT-NMD remote outcome measures group - consensus guidelines and recommendations
por: Lowes, L., et al.
Publicado: (2021)

PrEP Use and Persistence Among Young Sexual Minority Men 17–24 Years Old During the COVID-19 Pandemic
por: Hong, Chenglin, et al.
Publicado: (2021)

Clinical impact of COVID-19 on Turkish children with neurological and neuromuscular diseases: One center experience
por: Okur, Dicle Sener
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_97s1c92d4vgjg17b9ctep8qa18